INR 1490.75
(1.27%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 59.21 Billion INR | -33.08% |
2022 | 94.94 Billion INR | 7.61% |
2021 | 88.23 Billion INR | 14.33% |
2020 | 77.17 Billion INR | -3.23% |
2019 | 79.74 Billion INR | 5.28% |
2018 | 75.74 Billion INR | 12.25% |
2017 | 67.47 Billion INR | 3.65% |
2016 | 65.1 Billion INR | 9.03% |
2015 | 59.7 Billion INR | 18.99% |
2014 | 50.18 Billion INR | 28.36% |
2013 | 39.09 Billion INR | 24.33% |
2012 | 31.44 Billion INR | 25.77% |
2011 | 25 Billion INR | 24.35% |
2010 | 20.1 Billion INR | 21.67% |
2009 | 16.52 Billion INR | 13.12% |
2008 | 14.6 Billion INR | 58.11% |
2007 | 9.23 Billion INR | 26.23% |
2006 | 7.31 Billion INR | 21.91% |
2005 | 6 Billion INR | 38.34% |
2004 | 4.34 Billion INR | 32.11% |
2003 | 3.28 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 15.91 Billion INR | -7.12% |
2024 Q2 | 30.64 Billion INR | 5.25% |
2023 Q1 | 27.77 Billion INR | 45.92% |
2023 Q2 | 28.32 Billion INR | 1.96% |
2023 FY | 63.53 Billion INR | -33.08% |
2023 Q4 | 17.13 Billion INR | -38.2% |
2023 Q3 | 27.72 Billion INR | -2.13% |
2022 FY | 94.94 Billion INR | 7.61% |
2022 Q2 | 25.96 Billion INR | 7.97% |
2022 Q3 | 25.9 Billion INR | -0.22% |
2022 Q1 | 24.04 Billion INR | 32.54% |
2022 Q4 | 19.03 Billion INR | -26.51% |
2021 Q3 | 23.15 Billion INR | -2.53% |
2021 FY | 88.23 Billion INR | 14.33% |
2021 Q1 | 23.17 Billion INR | 52.75% |
2021 Q2 | 23.76 Billion INR | 2.54% |
2021 Q4 | 18.14 Billion INR | -21.67% |
2020 Q1 | 19.07 Billion INR | 17.19% |
2020 Q2 | 21.14 Billion INR | 10.84% |
2020 Q3 | 21.78 Billion INR | 3.01% |
2020 FY | 77.17 Billion INR | -3.23% |
2020 Q4 | 15.16 Billion INR | -30.36% |
2019 Q1 | 20.61 Billion INR | 38.0% |
2019 FY | 79.74 Billion INR | 5.28% |
2019 Q2 | 21.76 Billion INR | 5.58% |
2019 Q3 | 21.09 Billion INR | -3.09% |
2019 Q4 | 16.27 Billion INR | -22.82% |
2018 Q3 | 20.28 Billion INR | -4.09% |
2018 Q1 | 19.36 Billion INR | 2.27% |
2018 FY | 75.74 Billion INR | 12.25% |
2018 Q4 | 14.93 Billion INR | -26.38% |
2018 Q2 | 21.15 Billion INR | 9.24% |
2017 Q1 | 18.22 Billion INR | -20.67% |
2017 FY | 67.47 Billion INR | 3.65% |
2017 Q3 | 21.59 Billion INR | 11.73% |
2017 Q4 | 18.93 Billion INR | -12.33% |
2017 Q2 | 19.32 Billion INR | 6.06% |
2016 Q4 | 22.97 Billion INR | 24.69% |
2016 FY | 65.1 Billion INR | 9.03% |
2016 Q1 | 17.78 Billion INR | -8.12% |
2016 Q3 | 18.42 Billion INR | -2.52% |
2016 Q2 | 18.9 Billion INR | 6.3% |
2015 Q4 | 19.35 Billion INR | 24.33% |
2015 Q3 | 15.56 Billion INR | 0.89% |
2015 Q2 | 15.42 Billion INR | -4.32% |
2015 Q1 | 16.12 Billion INR | 19.86% |
2015 FY | 59.7 Billion INR | 18.99% |
2014 Q2 | 11.77 Billion INR | -2.33% |
2014 FY | 50.18 Billion INR | 28.36% |
2014 Q4 | 13.45 Billion INR | 11.87% |
2014 Q3 | 12.02 Billion INR | 2.14% |
2014 Q1 | 12.05 Billion INR | 9.04% |
2013 Q3 | 11.92 Billion INR | 13.17% |
2013 Q4 | 11.05 Billion INR | -7.31% |
2013 Q2 | 10.53 Billion INR | 30.36% |
2013 FY | 39.09 Billion INR | 24.33% |
2013 Q1 | 8.08 Billion INR | 54.22% |
2012 FY | 31.44 Billion INR | 25.77% |
2012 Q1 | 7.5 Billion INR | 0.0% |
2012 Q2 | 7.95 Billion INR | 6.0% |
2012 Q3 | 8.52 Billion INR | 7.25% |
2012 Q4 | 5.24 Billion INR | -38.54% |
2011 FY | 25 Billion INR | 24.35% |
2010 FY | 20.1 Billion INR | 21.67% |
2009 FY | 16.52 Billion INR | 13.12% |
2008 FY | 14.6 Billion INR | 58.11% |
2007 FY | 9.23 Billion INR | 26.23% |
2006 FY | 7.31 Billion INR | 21.91% |
2005 FY | 6 Billion INR | 38.34% |
2004 FY | 4.34 Billion INR | 32.11% |
2003 FY | 3.28 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott India Limited | 5.98 Billion INR | -889.237% |
Gland Pharma Limited | 3.86 Billion INR | -1433.498% |
GlaxoSmithKline Pharmaceuticals Limited | 4.35 Billion INR | -1259.028% |
Kopran Limited | 859.54 Million INR | -6789.392% |
Marksans Pharma Limited | 3.28 Billion INR | -1700.237% |
NGL Fine-Chem Limited | 816.16 Million INR | -7155.613% |
Pfizer Limited | 4.33 Billion INR | -1265.344% |
Sanofi India Limited | 3.69 Billion INR | -1503.512% |
SMS Pharmaceuticals Limited | 370.89 Million INR | -15866.249% |